Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

NCT01506336 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastro Intestinal Stromal Tumor

Interventions

DRUG: masitinib
DRUG: sunitinib

Sponsor

AB Science